CIK 0001434316
- Non-accelerated filer
- Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 651311552
- Phone
- +1 858-875-1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,525
- in 1 filing
Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-22 | Wolchko J Scott President and CEO | Option exercise | +20,000 | $6.62 | $132K | 423,793 |
| 2021-01-22 | Wolchko J Scott President and CEO | Sale | −12,767 | $97.23 | $1.2M | 411,026 |
| 2021-01-22 | Wolchko J Scott President and CEO | Sale | −7,638 | $98.45 | $752K | 403,388 |
| 2021-01-22 | Wolchko J Scott President and CEO | Sale | −6,520 | $99.35 | $648K | 396,868 |
| 2021-01-22 | Wolchko J Scott President and CEO | Sale | −3,075 | $100.01 | $308K | 393,793 |
| 2021-01-22 | Wolchko J Scott President and CEO | Option exercise · Stock Option (right to buy) | −10,000 | 170,000 | ||
| 2021-01-22 | Wolchko J Scott President and CEO | Option exercise · Stock Option (right to buy) | −20,000 | 34,846 | ||
| 2021-01-21 | Wolchko J Scott President and CEO | Option exercise | +30,000 | $2.73 | $82K | 423,793 |
| 2021-01-21 | Wolchko J Scott President and CEO | Sale | −2,540 | $100.16 | $254K | 421,253 |
| 2021-01-21 | Wolchko J Scott President and CEO | Sale | −5,993 | $101.09 | $606K | 415,260 |
| 2021-01-21 | Wolchko J Scott President and CEO | Sale | −3,300 | $101.91 | $336K | 411,960 |
| 2021-01-21 | Wolchko J Scott President and CEO | Sale | −3,895 | $103.23 | $402K | 408,065 |
| 2021-01-21 | Wolchko J Scott President and CEO | Sale | −9,156 | $104.13 | $953K | 398,909 |
| 2021-01-21 | Wolchko J Scott President and CEO | Sale | −4,271 | $105.25 | $450K | 394,638 |
| 2021-01-21 | Wolchko J Scott President and CEO | Sale | −645 | $106.03 | $68K | 393,993 |
| 2021-01-21 | Wolchko J Scott President and CEO | Sale | −200 | $106.96 | $21K | 393,793 |
| 2021-01-21 | Wolchko J Scott President and CEO | Option exercise · Stock Option (right to buy) | −30,000 | 180,000 | ||
| 2021-01-20 | Wolchko J Scott President and CEO | Grant or award | +43,231 | 393,793 | ||
| 2021-01-20 | Wolchko J Scott President and CEO | Grant or award · Stock Option (right to buy) | +16,441 | 16,441 | ||
| 2021-01-20 | Valamehr Bahram Chief Development Officer | Grant or award | +18,013 | 95,740 |
Page 23 of 26 · 503 trades